Crossing barriers: the burden of inflammatory bowel disease across Western Europe.

Fecha de publicación: 22/12/2023 Fecha Ahead of Print: 22/12/2023

Autores de IIS La Fe

Gianluca Pellino

Autor
Mónica Millán Scheiding

Autor

Participantes ajenos a IIS La Fe

Kumar A
Yassin N
Marley A
Bellato V
Foppa C
Myrelid P
Gros B
Avellaneda N
Catalan-Serra I
El-Hussuna A
Cunha Neves JA
Roseira J
Cunha MF
Verstockt B
Bettenworth D
Mege D
Brookes MJ

Grupos

Cirugía digestiva y Cuidados perioperatorios

Leader

Matteo Frasson

Abstract

An estimated 2.5-3 million individuals (0.4%) in Europe are affected by inflammatory bowel disease (IBD). Whilst incidence rates for IBD are stabilising across Europe, the prevalence is rising and subsequently resulting in a significant cost to the healthcare system of an estimated 4.6-5.6 billion euros per year. Hospitalisation and surgical resection rates are generally on a downward trend, which is contrary to the rising cost of novel medication. This signifies a large part of healthcare cost and burden. Despite publicly funded healthcare systems in most European countries, there is still wide variation in how patients receive and/or pay for biologic medication. This review will provide an overview and discuss the different healthcare systems within Western Europe and the barriers that affect overall management of a changing IBD landscape, including differences to hospitalisation and surgical rates, access to medication and clinical trial participation and recruitment. This review will also discuss the importance of standardising IBD management to attain high-quality care for all patients with IBD.

Datos de la publicación

ISSN/ISSNe:: 1756-283X, 1756-2848
Tipo:: Article
Páginas:: -
DOI:: 10.1177/17562848231218615
PubMed:: 38144422
Factor de Impacto:: 1,191 SCImago ℠
Cuartil:: Q1 SCImago ℠

Documentos

No hay documentos

Métricas

Filiaciones

Yassin N:: Department of Colorectal Surgery, University Hospitals Birmingham, Birmingham, UK
Marley A:: Department of Gastroenterology, The Royal Wolverhampton NHS Trust, Wolverhampton, UK
Bellato V:: Department of Minimally Invasive Surgery, University of Rome 'Tor Vergata', Rome, Italy
Foppa C:: Department of Biomedical Sciences, Humanitas University, Milan, Italy

Division of Colon and Rectal Surgery, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy
Pellino G:: Colorectal Surgery, Vall D'Hebron University Hospital, Universitat Autonoma de Barcelona, Barcelona, Spain

Department of Advanced Medical and Surgical Sciences, Universita degli Studi della Campania 'Luigi Vanvitelli', Naples, Italy
Myrelid P:: Department of Surgery, Linköping University Hospital, Linköping, Sweden

Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden
Millan M:: Department of Surgery, La Fe University and Polytechnic Hospital, University of Valencia, Valencia, Spain
Gros B:: Department of Gastroenterology and Hepatology, Reina Sofia University Hospital, Cordoba, Spain

Edinburgh IBD Unit, Western General Hospital, Edinburgh, UK
Avellaneda N:: General and Colorectal Surgery Department, CEMIC University Hospital, Buenos Aires, Argentina
Catalan-Serra I:: Department of Gastroenterology, Levanger Hospital, Nord-Trøndelag Hospital Trust, Levanger, Norway

Department of Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway

Centre of Molecular Inflammation Research, Norwegian University of Science and Technology, Trondheim, Norway
El-Hussuna A:: Open Source Research Organisation, Aalborg, Denmark
Cunha Neves JA:: Department of Gastroenterology, Algarve University Hospital Centre, Portimão, Portugal

Algarve Biomedical Centre, University of Algarve, Faro, Portugal
Roseira J:: Department of Gastroenterology, Algarve University Hospital Centre, Portimão, Portugal

Algarve Biomedical Centre, University of Algarve, Faro, Portugal
Cunha MF:: Algarve Biomedical Centre, University of Algarve, Faro, Portugal

Department of Colorectal Surgery, Algarve University Hospital Centre, Portimão, Portugal
Verstockt B:: Department of Gastroenterology and Hepatology, University Hospitals Leuven, KU Leuven, Belgium

Department of Chronic Diseases and Metabolism, KU Leuven, Leuven, Belgium
Bettenworth D:: CED Schwerpunktpraxis, Münster, Germany

Medical Faculty, University of Münster, Münster, Germany
Mege D:: Department of Digestive and Oncology Surgery, Timone University Hospital, Marseille, France
Brookes MJ:: Department of Gastroenterology, The Royal Wolverhampton NHS Trust, Wolverhampton, UK